Speaker illustration

Doctor Avinainder Singh

Brigham and Women's Hospital, Boston (United States of America)

Bortezomib: an effective therapy even in cardiac AL patients previously deemed unsalvageable

Event: ESC CONGRESS 2016

Topic: Drug therapy

Session: Cardiomyopathy with preserved ejection fraction: Amyloidosis and hypertension

Thumbnail

Survival with bortezomib in light chain cardiac amyloidosis: a boon that lessens the gloom

Event: ESC CONGRESS 2016

Topic: Cardiomyopathies

Session: Cardiomyopathies

Thumbnail

This platform is supported by

logo Novo Nordisk